1. - Clinica malattie apparato respiratorio

2. GESTIONE DELLA BPCO
6. Ward MM, Javitz HS, Smith WM et al: Direct medical
cost of chronic obstructive pulmonary disease
in the USA. Respir Med 2000:1123-1129.
7. Mannino DM: COPD: epidemiology, prevalence,
morbidity and mortality, and disease heterogeneity.
Chest 2002; 121(Suppl.5):121S-126S. Review.
8. Dal Negro R, Berto P,Tognella S et al: Cost-of-illness
of lung disease in the TriVeneto Region, Italy:
the GOLD study. Monaldi Arch Chest Dis 2002;
57:1-7.
9. Eisner MD,Yelin EH,Trupin L et al.The influence
of chronic respiratory conditions on health status
and work disability. Am J Public Health 2002;
92:1506-1513.
10. Sin DD, Stafinski T, Ng YC et al:The impact of chronic
obstructive pulmonary disease on work loss
in the United States. Am J Respir Crit Care Med
2002; 165(5):704-707.
11. Michaud CM, Murray CJ, Bloom BR: Burden of
disease—implications for future research. JAMA
2001; 285:535-539.
12. Lopez AD e Murray CC:The global burden of disease,
1990-2020. Nat Med 1998; 4:1241-1243.
13. Parrott S, Godfrey C, Raw M et al:A Guidance for
Commissioners on the Cost Effectiveness of
Smoking Cessation Interventions. Thorax 1998;
53(Suppl.5):S2-S37.
14. Godtfredsen NS, Holst C, Prescott E et al: Smoking
reduction, smoking cessation, and mortality: a 16-
year follow-up of 19,732 men and women from The
Copenhagen Centre for Prospective Population
Studies. Am J Epidemiol 2002; 156(11):994-1001.
15. Godtfredsen NS,Vestbo J, Osler M et al: Risk of hospital
admission for COPD following smoking cessation
and reduction: a Danish population study.
Thorax 2002; 57:967-972.
16. Feenstra TL, van Genugten ML, Hoogenveen RT
et al:The impact of aging and smoking on the future
burden of chronic obstructive pulmonary disease:
a model analysis in the Netherlands.Am J Respir
Crit Care Med 2001; 164:590-596.
17. National Heart,Lung,and Blood Institute:1998 fact
book. Hyattsville, MD: US Department of Health
and Human Services, National Heart, Lung, and
Blood Institute, 1999.
18. Prescott E, Bjerg AM, Andersen PK et al: Gender
difference in smoking effects on lung function and
risk of hospitalization for COPD: results from a Danish
longitudinal population study. Eur Respir J
1997; 10:822-827.
19. US Bureau of the Census: Statistical abstract of the
United States, 1997. 117 th ed.Washington, DC: US
Department of Commerce, US Bureau of the Census,
1997.
20. Meyer PA, Mannino DM, Redd SC et al: Characteristics
of adults dying with COPD. Chest 2002;
122:2003-2008.
21. Viegi G e Di Pede C: Chronic obstructive lung diseases
and occupational exposure. Curr Opin Allergy
Clin Immunol 2002; 2:115-121.
22. Hnizdo E, Sullivan PA, Bang KM et al: Association
between chronic obstructive pulmonary disease and
employment by industry and occupation in the US
population: a study of data from the Third National
Health and Nutrition Examination Survey. Am
J Epidemiol 2002; 156:738-746.
23. Pauwels RA, Buist AS, Calverley PM et al: Global
strategy for the diagnosis, management, and prevention
of chronic obstructive pulmonary disease.NHL-
BI/WHO Global Initiative for Chronic Obstructive
Lung Disease (GOLD) Workshop summary. Am
J Respir Crit Care Med 2001; 163:1256-1276.
24. Donato F, Pasini GF, Buizza MA et al: Tobacco
smoking, occupational exposure and chronic respiratory
disease in an Italian industrial area. Monaldi
Arch Chest Dis 2000; 55:194-200.
25. Leigh JP, Romano PS, Schenker MB et al: Costs of
occupational COPD and asthma. Chest 2002;
121:264-272.
26. Moscato G e Rampulla C: Costs of occupational
asthma and occupational COPD.Curr Opin Allergy
Clin Immunol 2003, in stampa.
27. Anto JM,Vermeire P,Vestbo J et al: Epidemiology
of chronic obstructive pulmonary disease. Eur Respir
J 2001; 17:982-994. Review.
28. Sunyer J: Urban air pollution and chronic obstructive
pulmonary disease: a review. Eur Respir J 2001;
17:1024-1033.
29. Hagedorn SD:Acute exacerbations of COPD. How
to evaluate severity and treat the underlying cause.
Postgrad Med 1992; 91:105-107, 110-112.
30. Badgett RG e Tanaka DJ: Is screening for chronic
obstructive pulmonary disease justified Prev Med
1997; 26:466-472. Review.
31. Pistelli R, Sammarro S, Giuntini C: Programmi di
Screening. In Giuntini C, Fabbri LS, Grassi V (Eds):
I quaderni della BPCO. Il volto della BPCO che
cambia. UTET Periodici Scientifici, Milano 2003; 6.
32. Butler JR: Economic evaluations of screening programs:
a review of methods and results. Clin Chim
Acta 2002; 315:331-340. Review.
71